Gregory J. Keir

Rituximab in severe, treatment‐refractory interstitial lung disease

Gregory J. Keir, Toby M. Maher, Damien Ming et al. · Respirology · 2013 · 257 citations

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

Toby M. Maher, Veronica A Tudor, Peter Saunders et al. · The Lancet Respiratory Medicine · 2022 · 245 citations · Full text

An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study

Simon LF Walsh, Athol U. Wells, Nicola Sverzellati et al. · The Lancet Respiratory Medicine · 2014 · 228 citations · Full text

Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

Helen E. Jo, Ian Glaspole, Christopher Grainge et al. · European Respiratory Journal · 2017 · 227 citations · Full text

Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants

Simon Walsh, Nicola Sverzellati, Anand Devaraj et al. · Thorax · 2013 · 221 citations · Full text